PreveCeutical Medical Inc. - CEO, Stephen Van Deventer.
CEO, Stephen Van Deventer.
Source: PreveCeutical Medical Inc.
  • PreveCeutical Medical Inc. (PREV) has selected ICON PLC to complete work on the analgesic program’s clinical development
  • PreveCeutical’s analgesic program is designing a non-addictive painkiller to meet the requirements due to the global abuse of painkillers
  • ICON is a global healthcare intelligence and clinical research organization that provides outsourced services
  • PreveCeutical will begin clinical development with ICON during its first fiscal quarter and work with regulators for any potential fast-track provisions
  • PreveCeutical Medical Inc. (PREV) is up 16.67 per cent, trading at $0.03 per share as of 1:35 p.m. EST

PreveCeutical Medical (PREV) has selected ICON PLC to complete work on the analgesic program’s clinical development.

PreveCeutical is a health sciences company that develops options for preventive and curative therapies utilizing organic and natural products. Its analgesic program is designing a non-addictive painkiller to meet the requirements due to the global abuse of painkillers.

ICON is a global healthcare intelligence and clinical research organization. It provides outsourced services to pharmaceutical, biotechnology, medical device, government, and public health organizations.

PreveCeutical will begin clinical development with ICON during its first fiscal quarter and work with regulators for any potential fast-track provisions.  

The work will include conducting a comprehensive gap analysis to confirm current conclusions as well as identify any potential additional nonclinical studies that will be needed to support Investigational New Drug and Clinical Trial Application submissions.

ICON will also help with the construction of a clinical development plan for the program’s phase one through phase three studies.

PreveCeutical’s CEO, Stephen Van Deventer, commented,

 “After many reviews of the best global CROs, we have selected ICON as we believe that they are one of the best in the world, with experience in all clinical matters and, more importantly, pain treatment therapies.”

PreveCeutical Medical Inc. (PREV) is up 16.67 per cent, trading at $0.03 per share as of 1:35 p.m. EST.


More From The Market Online

How this junior is unlocking unprecedented potential in Alaska 

Freegold Ventures (TSX:FVL) is well-positioned to be a leader in the state of Alaska's gold mining sector and investors are paying attention.

Eric Sprott reduces exposure to TRU Precious Metals

Billionaire investor Eric Sprott allows 9 million warrants for shares of TRU Precious Metals (TSXV:TRU) to expire unexercised. 

Canadian uranium miner to commence Nunavut property exploration

Lexston Mining Corp. (CSE:LEXT) is about to begin its inaugural 2024 geological exploration program on its Itza uranium property in Nunavut.